Skip to main navigation Skip to search Skip to main content

The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans

  • P. E. Dekkers
  • , T. ten Hove
  • , F. N. Lauw
  • , H. R. Koene
  • , P. Lumley
  • , S. J. van Deventer
  • , T. van der Poll

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Metalloproteinases have been implicated in the cleavage of a number of cell surface immune receptors. Oral administration of the metalloproteinase inhibitor GI5402 attenuated the release of soluble CD27 and CD16 into the circulation after intravenous endotoxin injection in healthy humans
Original languageEnglish
Pages (from-to)3036-3039
JournalInfection and immunity
Volume68
Issue number5
DOIs
Publication statusPublished - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans'. Together they form a unique fingerprint.

Cite this